OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

CUSIP: 68277Q105

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
12,837,443
Total 13F shares
10,219,418
Share change
-559,478
Total reported value
$28,103,553
Price per share
$2.75
Number of holders
41
Value change
-$1,295,979
Number of buys
15
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 68277Q105?
CUSIP 68277Q105 identifies OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR) as of Q3 2025

As of 30 Sep 2025, OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,219,418 shares. The largest 10 holders included ACORN CAPITAL ADVISORS, LLC, CITADEL ADVISORS LLC, Shay Capital LLC, VANGUARD GROUP INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Vestal Point Capital, LP, BlackRock, Inc., StepStone Group LP, CANTOR FITZGERALD, L. P., and NEA Management Company, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.